The Accessibility 100 -- The Top Innovators and Impact-Makers
Accessibility is about far more than wheelchair ramps or live captioning. The field has emerged as a bustling innovation hub, an educational imperative and—unapologetically—a business sector waiting to explode.
'This isn't charity. This isn't just 'doing the right thing,'' says Mike Buckley, CEO of Be My Eyes, whose software in Ray-Ban/Meta sunglasses connects blind and low-vision people to live, seeing volunteers who help them navigate the world. 'It's about seeing a market, innovating, scaling and ultimately ROI. Venture capital is getting more and more involved every day.'
The Accessibility 100—a new Forbes list, launching June 17—will unveil the 100 biggest innovators and impact-makers in the field of accessibility for people with disabilities. The list will include the top global forces in accessibility-related fields ranging from consumer products and software to education, AI-driven robotics, sports and recreation, travel, the workplace and the arts, among others. Some will be juggernaut tech companies leveraging their reach and resources to embed their products with crucial accessibility features; others will be smaller entrepreneurs whose innovations are poised to change the world.
The Accessibility 100 will be launched on Forbes.com alongside a live panel discussion at the Cannes Lions Festival in France.
For the purpose of this list, the disability categories that listees are impacting include the following:
For the purposes of this list, 'Accessibility' is defined as software, devices and services that allow people with disabilities to have access to information, content, public spaces and experiences. Examples include:
The Accessibility 100 was compiled through interviews with more than 400 experts, along with an expert advisory panel. Emphasis was placed on breadth of true impact across the widest landscape. The final selections will feature companies and individuals from more than 15 countries.
—
As with all Forbes lists, there was no fee for any company or person to be considered for the Accessibility 100. For questions about the list, please email Alan Schwarz at aschwarz [at] forbes.com.
Forbes
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Type 2 diabetes patients set for major shake-up in care
People with type 2 diabetes in England are to get the biggest shake up of care in a decade which could see them offered treatments, including jabs that aid weight-loss, sooner. The health service should move from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart attacks, according to new draft guidance from the National Institute for Health and Care Excellence (Nice). This includes making newer type 2 diabetes drugs, known as SGLT-2 inhibitors, a first-line treatment option in a move that could eventually help save tens of thousands of lives. SGLT-2 inhibitors, which include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, are once-a-day tablets that reduce blood sugar levels by helping the kidneys remove glucose, which is passed from the body through urine. However, analysis by Nice found these drugs are under-prescribed. The new guidelines recommend patients who cannot tolerate metformin – the first-choice in type 2 diabetes medication – should start with an SGLT-2 inhibitor on its own. The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, Nice said. It is estimated the change could save almost 22,000 lives once uptake reaches 90% of the population. Nice also suggests some groups of patients would also benefit from GLP-1 receptor agonists such as liraglutide or semaglutide sooner, rather than keeping them for the later stages of treatment. Semaglutide, sold under the brand name Ozempic, is licensed in the UK to treat type 2 diabetes, while its other brand – Wegovy – is also used by the NHS to help obese people lose weight. Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice, said: 'This guidance means more people will be offered medicines where it is right to do so to reduce their future risk of ill health. 'This represents a significant evolution in how we approach type 2 diabetes treatment. 'We're moving beyond simply managing blood sugar to taking a holistic view of a person's health, particularly their cardiovascular and kidney health. 'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes and other serious complications before they occur. 'This is particularly important given that cardiovascular disease is the leading cause of death in people with type 2 diabetes.' Around 4.6 million people in the UK are living with diabetes, with nine in 10 of those having type 2. However, it is estimated that a further 1.3 million people may have undiagnosed type 2 diabetes. Nice analysed the records of 590,000 people and found SGLT-2 inhibitors are under-prescribed, particularly to women, older people, and black patients. Prof Benger added: 'The evidence from our analysis is clear. There are prescribing gaps that need to be addressed. 'The guideline update published today will help to increase equitable uptake of SGLT-2 inhibitors, which we know can prevent serious health complications.' Dr Waqaar Shah, chairman of the guideline committee, added: 'We know that SGLT-2 inhibitors are currently under-prescribed, and our health economics analysis shows that people living in the most deprived areas would particularly benefit from universal access to these treatments. 'These recommendations could help reduce health inequalities while providing better outcomes for everyone.' Elsewhere, the draft guidance suggests different treatments for diabetes patients with certain characteristics or health conditions. These include adults with cardiovascular disease, who should be offered a triple therapy including a GLP-1 receptor agonist. Meanwhile, adults diagnosed with type 2 diabetes before 40 should be offered dual therapy before a GLP-1 receptor agonist is considered, while patients with chronic kidney disease should have tailored recommendations based on their kidney function. A public consultation on the new Nice guidelines is open until October 2. Douglas Twenefour, head of clinical at Diabetes UK, said: 'This long-awaited announcement propels type 2 diabetes treatment into the 21st century. 'Boosting access to newer treatments will be transformative for people with type 2 diabetes, while ensuring the UK keeps pace with the global momentum in treating the condition. 'The majority of people with type 2 diabetes are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications. 'Diabetes is a leading cause of cardiovascular disease, and tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease. 'These guidelines could go a long way to easing the burden of living with this relentless condition, as well as helping to address inequities in type 2 diabetes treatments and outcomes.'
CNET
20 minutes ago
- CNET
This Phone For Kids Will Block the Capture of Nude Content From Within the Camera
Among the biggest concerns of parents whose kids own a smartphone must surely be the knowledge that there's a whole bunch of nude content out there on the internet for them to stumble across. Likely more worrying still is the thought that their precious offspring may be tempted to make such content themselves. Finnish phone maker HMD has been on a mission for the past few years to make phone ownership a safer prospect for children via its Better Phones Project -- and it might have come up with a solution to calm the nerves of concerned parents. On Wednesday, the company unveiled the HMD Fuse phone, which comes with built-in AI-powered technology to prevent children from filming and sending nude content, as well as well from seeing and saving sexual images -- even from within a livestream. "This is more than a product," said James Robinson, VP of HMD Family. "It's a safety net, a statement of intent, and a response." The AI (called HarmBlock Plus) has been created by cybersecurity SafeToNet, and is embedded into the phone (including the camera), which according to HMD, makes it impossible to bypass. It's apparently been ethically trained on 22 million harmful nude images and works offline. "HarmBlock Plus can't be removed, tricked, or worked around," said SafeToNet founder Richard Pursey. "It doesn't collect personal data. It just protects every time, across every app, including VPNs, with zero loopholes." Parental controls, similar to those available on the Fusion X1, which HMD introduced at MWC in March, will also allow for supervision and management of a child's phone use. This can be scaled back as a kid grows older and requires more independence. The phone is launching exclusively on Vodafone in the UK, where the recent introduction of the Online Safety Act means strict age verification rules are now required to prevent minors from accessing harmful content online. It will cost £33 per month, with a £30 up-front fee and is set to launch in other countries in the coming months, starting with Australia. There's no indication the Fuse will be headed to the US, where the company has in the past few months scaled back its operations.
CNN
21 minutes ago
- CNN
UK government walks back controversial Apple ‘back door' demand after Trump administration pressure
UK Digital privacy Tech giants Digital securityFacebookTweetLink Follow The UK government has backed down on a controversial demand for Apple to build a 'back door' into its technology to access private user data following pressure from the Trump administration. The order could have undermined a key security promise Apple makes to its users — the company has said it has not and would never build a backdoor or 'master key' to its products — and compromised privacy for users globally. UK officials had reportedly sought access to encrypted data that users around the world store in iCloud, materials that even the iPhone maker itself is typically unable to access. US Director of National Intelligence Tulsi Gabbard said on X Monday that the United Kingdom 'agreed to drop its mandate for Apple to provide a 'back door' that would have enabled access to the protected encrypted data of American citizens and encroached on our civil liberties.' Gabbard said that over the 'past few months,' she had been 'working closely with our partners in the UK,' alongside President Donald Trump and Vice President JD Vance, on the agreement. A source familiar with the discussions told CNN that Gabbard spoke with her counterpart in the UK, Deputy National Security Advisory Matt Collins, a few times about the issue, including once when the UK delegation visited the White House. Vance was also personally involved in reaching a deal, engaging in direct conversations with British government officials to come to what was considered a 'mutually beneficial' agreement for both countries, a White House official told CNN. No further details on the agreement were provided. The British Home Office reportedly made the order under the Investigatory Powers Act that lets UK law enforcement compel access to communications and metadata from tech companies in secret, although the agency never confirmed the demand. The Home Office did not immediately respond to CNN's request for comment on Tuesday. Reports about the order earlier this year quickly raised alarm among security experts and tech leaders who worried that Apple could be used by a foreign government to spy on its users. The company in February rolled back a data security feature for iCloud called Advanced Data Protection (ADP) for users in the United Kingdom. The feature provides optional end-to-end encryption for personal data such as photos and messages, meaning only the user who holds the account, not even the company itself could view that information. Without end-to-end encryption, Apple could have access to users' data, meaning law enforcement could legally compel the company to hand it over to aid in investigating crimes. Removing the feature for UK users was widely viewed as an effort to protect more advanced security for users elsewhere in the world in the face of the UK government's demand for a technical back door. But it didn't necessarily address the UK's demand for access to user data globally. Apple said in a statement at the time that it was 'gravely disappointed' to no longer offer ADP to UK users, 'given the continuing rise of data breaches and other threats to customer privacy.' Apple did not immediately respond to CNN's request for comment on the UK government's retreat from the demand. Tech executives, including Apple CEO Tim Cook, have sought to foster close relationships with Trump since he took office in hopes of gaining his support on key policy and regulatory issues. The UK agreement marks the latest instance of the Trump administration convincing a foreign government to walk back regulation of an American tech company. In June, Canada said it would rescind a digital services tax — which Trump had called a 'direct and blatant attack' on the United States and its companies — to restart trade negotiations with the US.
